We are proud to announce that the results of Leaders free and Oppose trials, sponsored respectively by Biosensors and Occlutech, and which were managed by CERC will be presented during this year’s TCT congress:
LEADERS FREE : Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk. Presented by Dr Philip Urban on Sunday , Oct 30. 12:45 PM. Main Arena
LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial . Presented by Pr Didier Carriée on Monday, Oct 31. 1:15 PM. Room 143A
OPPOSE: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry. Presented by David Hildick-Smith on Monday , Oct 31. 12:45 PM. Room 144B
Person to be contacted during the congress: